The global market for Invasive Brain Monitoring Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Invasive Brain Monitoring Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Invasive Brain Monitoring Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Invasive Brain Monitoring Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Invasive Brain Monitoring Device include Natus Medical Inc (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthineers (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (US), Medtronic plc (Ireland) and CAS Medical Systems, Inc (US), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Invasive Brain Monitoring Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Invasive Brain Monitoring Device by region & country, by Type, and by Application.
The Invasive Brain Monitoring Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Brain Monitoring Device.
麻豆原创 Segmentation
By Company
Natus Medical Inc (US)
Nihon Kohden Corporation (Japan)
Philips Healthcare (Netherlands)
GE Healthcare (U.K.)
Siemens Healthineers (Germany)
Compumedics Ltd. (Australia)
Electrical Geodesics Incorporated (US)
Medtronic plc (Ireland)
CAS Medical Systems, Inc (US)
Advanced Brain Monitoring (US)
Segment by Type:
Electroencephalography (EEG) Devices
Magnetoencephalography (MEG) Devices
Transcranial Doppler (TCD) Devices
Intracranial Pressure (ICP) Monitors
Cerebral Oximeters
Magnetic Resonance Imaging (MRI) Devices
Computerized Tomography (CT) Devices
Positron Emission Tomography (PET) Devices
Sleep Monitoring Devices
Electromyography (EMG) Devices
Segment by Application
Epilepsy
Dementia
Parkinson鈥檚 Disease
Huntington's Disease
Headache Disorders
Stroke
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Invasive Brain Monitoring Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Invasive Brain Monitoring Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Invasive Brain Monitoring Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Invasive Brain Monitoring Device Product Introduction
1.2 Global Invasive Brain Monitoring Device 麻豆原创 Size Forecast
1.2.1 Global Invasive Brain Monitoring Device Sales Value (2019-2030)
1.2.2 Global Invasive Brain Monitoring Device Sales Volume (2019-2030)
1.2.3 Global Invasive Brain Monitoring Device Sales Price (2019-2030)
1.3 Invasive Brain Monitoring Device 麻豆原创 Trends & Drivers
1.3.1 Invasive Brain Monitoring Device Industry Trends
1.3.2 Invasive Brain Monitoring Device 麻豆原创 Drivers & Opportunity
1.3.3 Invasive Brain Monitoring Device 麻豆原创 Challenges
1.3.4 Invasive Brain Monitoring Device 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Invasive Brain Monitoring Device Players Revenue Ranking (2023)
2.2 Global Invasive Brain Monitoring Device Revenue by Company (2019-2024)
2.3 Global Invasive Brain Monitoring Device Players Sales Volume Ranking (2023)
2.4 Global Invasive Brain Monitoring Device Sales Volume by Company Players (2019-2024)
2.5 Global Invasive Brain Monitoring Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Invasive Brain Monitoring Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Invasive Brain Monitoring Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Invasive Brain Monitoring Device
2.9 Invasive Brain Monitoring Device 麻豆原创 Competitive Analysis
2.9.1 Invasive Brain Monitoring Device 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Invasive Brain Monitoring Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Brain Monitoring Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Electroencephalography (EEG) Devices
3.1.2 Magnetoencephalography (MEG) Devices
3.1.3 Transcranial Doppler (TCD) Devices
3.1.4 Intracranial Pressure (ICP) Monitors
3.1.5 Cerebral Oximeters
3.1.6 Magnetic Resonance Imaging (MRI) Devices
3.1.7 Computerized Tomography (CT) Devices
3.1.8 Positron Emission Tomography (PET) Devices
3.1.9 Sleep Monitoring Devices
3.1.10 Electromyography (EMG) Devices
3.2 Global Invasive Brain Monitoring Device Sales Value by Type
3.2.1 Global Invasive Brain Monitoring Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Invasive Brain Monitoring Device Sales Value, by Type (2019-2030)
3.2.3 Global Invasive Brain Monitoring Device Sales Value, by Type (%) (2019-2030)
3.3 Global Invasive Brain Monitoring Device Sales Volume by Type
3.3.1 Global Invasive Brain Monitoring Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Invasive Brain Monitoring Device Sales Volume, by Type (2019-2030)
3.3.3 Global Invasive Brain Monitoring Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Invasive Brain Monitoring Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Epilepsy
4.1.2 Dementia
4.1.3 Parkinson鈥檚 Disease
4.1.4 Huntington's Disease
4.1.5 Headache Disorders
4.1.6 Stroke
4.1.7 Others
4.2 Global Invasive Brain Monitoring Device Sales Value by Application
4.2.1 Global Invasive Brain Monitoring Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Invasive Brain Monitoring Device Sales Value, by Application (2019-2030)
4.2.3 Global Invasive Brain Monitoring Device Sales Value, by Application (%) (2019-2030)
4.3 Global Invasive Brain Monitoring Device Sales Volume by Application
4.3.1 Global Invasive Brain Monitoring Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Invasive Brain Monitoring Device Sales Volume, by Application (2019-2030)
4.3.3 Global Invasive Brain Monitoring Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Invasive Brain Monitoring Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Invasive Brain Monitoring Device Sales Value by Region
5.1.1 Global Invasive Brain Monitoring Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Invasive Brain Monitoring Device Sales Value by Region (2019-2024)
5.1.3 Global Invasive Brain Monitoring Device Sales Value by Region (2025-2030)
5.1.4 Global Invasive Brain Monitoring Device Sales Value by Region (%), (2019-2030)
5.2 Global Invasive Brain Monitoring Device Sales Volume by Region
5.2.1 Global Invasive Brain Monitoring Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Invasive Brain Monitoring Device Sales Volume by Region (2019-2024)
5.2.3 Global Invasive Brain Monitoring Device Sales Volume by Region (2025-2030)
5.2.4 Global Invasive Brain Monitoring Device Sales Volume by Region (%), (2019-2030)
5.3 Global Invasive Brain Monitoring Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Invasive Brain Monitoring Device Sales Value, 2019-2030
5.4.2 North America Invasive Brain Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Invasive Brain Monitoring Device Sales Value, 2019-2030
5.5.2 Europe Invasive Brain Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Invasive Brain Monitoring Device Sales Value, 2019-2030
5.6.2 Asia Pacific Invasive Brain Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Invasive Brain Monitoring Device Sales Value, 2019-2030
5.7.2 South America Invasive Brain Monitoring Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Invasive Brain Monitoring Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Invasive Brain Monitoring Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Invasive Brain Monitoring Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Invasive Brain Monitoring Device Sales Value
6.2.1 Key Countries/Regions Invasive Brain Monitoring Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Invasive Brain Monitoring Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Invasive Brain Monitoring Device Sales Value, 2019-2030
6.3.2 United States Invasive Brain Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Invasive Brain Monitoring Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Invasive Brain Monitoring Device Sales Value, 2019-2030
6.4.2 Europe Invasive Brain Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Invasive Brain Monitoring Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Invasive Brain Monitoring Device Sales Value, 2019-2030
6.5.2 China Invasive Brain Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Invasive Brain Monitoring Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Invasive Brain Monitoring Device Sales Value, 2019-2030
6.6.2 Japan Invasive Brain Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Invasive Brain Monitoring Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Invasive Brain Monitoring Device Sales Value, 2019-2030
6.7.2 South Korea Invasive Brain Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Invasive Brain Monitoring Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Invasive Brain Monitoring Device Sales Value, 2019-2030
6.8.2 Southeast Asia Invasive Brain Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Invasive Brain Monitoring Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Invasive Brain Monitoring Device Sales Value, 2019-2030
6.9.2 India Invasive Brain Monitoring Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Invasive Brain Monitoring Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Natus Medical Inc (US)
7.1.1 Natus Medical Inc (US) Company Information
7.1.2 Natus Medical Inc (US) Introduction and Business Overview
7.1.3 Natus Medical Inc (US) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Natus Medical Inc (US) Invasive Brain Monitoring Device Product Offerings
7.1.5 Natus Medical Inc (US) Recent Development
7.2 Nihon Kohden Corporation (Japan)
7.2.1 Nihon Kohden Corporation (Japan) Company Information
7.2.2 Nihon Kohden Corporation (Japan) Introduction and Business Overview
7.2.3 Nihon Kohden Corporation (Japan) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Nihon Kohden Corporation (Japan) Invasive Brain Monitoring Device Product Offerings
7.2.5 Nihon Kohden Corporation (Japan) Recent Development
7.3 Philips Healthcare (Netherlands)
7.3.1 Philips Healthcare (Netherlands) Company Information
7.3.2 Philips Healthcare (Netherlands) Introduction and Business Overview
7.3.3 Philips Healthcare (Netherlands) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Philips Healthcare (Netherlands) Invasive Brain Monitoring Device Product Offerings
7.3.5 Philips Healthcare (Netherlands) Recent Development
7.4 GE Healthcare (U.K.)
7.4.1 GE Healthcare (U.K.) Company Information
7.4.2 GE Healthcare (U.K.) Introduction and Business Overview
7.4.3 GE Healthcare (U.K.) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GE Healthcare (U.K.) Invasive Brain Monitoring Device Product Offerings
7.4.5 GE Healthcare (U.K.) Recent Development
7.5 Siemens Healthineers (Germany)
7.5.1 Siemens Healthineers (Germany) Company Information
7.5.2 Siemens Healthineers (Germany) Introduction and Business Overview
7.5.3 Siemens Healthineers (Germany) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Siemens Healthineers (Germany) Invasive Brain Monitoring Device Product Offerings
7.5.5 Siemens Healthineers (Germany) Recent Development
7.6 Compumedics Ltd. (Australia)
7.6.1 Compumedics Ltd. (Australia) Company Information
7.6.2 Compumedics Ltd. (Australia) Introduction and Business Overview
7.6.3 Compumedics Ltd. (Australia) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Compumedics Ltd. (Australia) Invasive Brain Monitoring Device Product Offerings
7.6.5 Compumedics Ltd. (Australia) Recent Development
7.7 Electrical Geodesics Incorporated (US)
7.7.1 Electrical Geodesics Incorporated (US) Company Information
7.7.2 Electrical Geodesics Incorporated (US) Introduction and Business Overview
7.7.3 Electrical Geodesics Incorporated (US) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Electrical Geodesics Incorporated (US) Invasive Brain Monitoring Device Product Offerings
7.7.5 Electrical Geodesics Incorporated (US) Recent Development
7.8 Medtronic plc (Ireland)
7.8.1 Medtronic plc (Ireland) Company Information
7.8.2 Medtronic plc (Ireland) Introduction and Business Overview
7.8.3 Medtronic plc (Ireland) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Medtronic plc (Ireland) Invasive Brain Monitoring Device Product Offerings
7.8.5 Medtronic plc (Ireland) Recent Development
7.9 CAS Medical Systems, Inc (US)
7.9.1 CAS Medical Systems, Inc (US) Company Information
7.9.2 CAS Medical Systems, Inc (US) Introduction and Business Overview
7.9.3 CAS Medical Systems, Inc (US) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.9.4 CAS Medical Systems, Inc (US) Invasive Brain Monitoring Device Product Offerings
7.9.5 CAS Medical Systems, Inc (US) Recent Development
7.10 Advanced Brain Monitoring (US)
7.10.1 Advanced Brain Monitoring (US) Company Information
7.10.2 Advanced Brain Monitoring (US) Introduction and Business Overview
7.10.3 Advanced Brain Monitoring (US) Invasive Brain Monitoring Device Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Advanced Brain Monitoring (US) Invasive Brain Monitoring Device Product Offerings
7.10.5 Advanced Brain Monitoring (US) Recent Development
8 Industry Chain Analysis
8.1 Invasive Brain Monitoring Device Industrial Chain
8.2 Invasive Brain Monitoring Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Invasive Brain Monitoring Device Sales Model
8.5.2 Sales Channel
8.5.3 Invasive Brain Monitoring Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Natus Medical Inc (US)
Nihon Kohden Corporation (Japan)
Philips Healthcare (Netherlands)
GE Healthcare (U.K.)
Siemens Healthineers (Germany)
Compumedics Ltd. (Australia)
Electrical Geodesics Incorporated (US)
Medtronic plc (Ireland)
CAS Medical Systems, Inc (US)
Advanced Brain Monitoring (US)
听
听
*If Applicable.
